Literature DB >> 16267745

Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?

Stephen D Lawn, Landon Myer, Robin Wood.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16267745     DOI： 10.1086/498030

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  Remote sensing of HIV care programmes using centrally collected laboratory results: can we monitor ART programme effectiveness?

Authors:  Carl Morrow; Alison Munro; Marisa Wilke; Ruth Stark; Robin Wood
Journal:  S Afr Med J       Date:  2012-03-02

2.  Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew Gray; Tanuja Gengiah; Gonasagrie Nair; Sheila Bamber; Aarthi Singh; Munira Khan; Jacqueline Pienaar; Wafaa El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

3.  Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa.

Authors:  Matthew P Fox; Alana Brennan; Mhairi Maskew; Patrick MacPhail; Ian Sanne
Journal:  Trop Med Int Health       Date:  2010-02-17       Impact factor: 2.622

4.  Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study.

Authors:  Suzanne M Ingle; Margaret May; Kerry Uebel; Venessa Timmerman; Eduan Kotze; Max Bachmann; Jonathan A C Sterne; Matthias Egger; Lara Fairall
Journal:  S Afr Med J       Date:  2010-10-01

5.  Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.

Authors:  Suzanne M Ingle; Margaret May; Kerry Uebel; Venessa Timmerman; Eduan Kotze; Max Bachmann; Jonathan A C Sterne; Matthias Egger; Lara Fairall
Journal:  AIDS       Date:  2010-11-13       Impact factor: 4.177

Review 6.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

7.  Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy.

Authors:  Fred Lutwama; Ronnie Serwadda; Harriet Mayanja-Kizza; Hasan M Shihab; Allan Ronald; Moses R Kamya; David Thomas; Elizabeth Johnson; Thomas C Quinn; Richard D Moore; Lisa A Spacek
Journal:  J Acquir Immune Defic Syndr       Date:  2008-07-01       Impact factor: 3.731

8.  Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.

Authors:  Tom H Boyles; Lynne S Wilkinson; Rory Leisegang; Gary Maartens
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

9.  Association of first-line and second-line antiretroviral therapy adherence.

Authors:  Habib O Ramadhani; John A Bartlett; Nathan M Thielman; Brian W Pence; Stephen M Kimani; Venance P Maro; Mtumwa S Mwako; Lazaro J Masaki; Calvin E Mmbando; Mary G Minja; Eileen S Lirhunde; William C Miller
Journal:  Open Forum Infect Dis       Date:  2014-09-09       Impact factor: 3.835

10.  Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.

Authors:  Julia Tabatabai; Ireen Namakhoma; Hannock Tweya; Sam Phiri; Paul Schnitzler; Florian Neuhann
Journal:  Glob Health Action       Date:  2014-09-30       Impact factor: 2.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.